Our News on Newswise

Newswise: 61a69e2099789_USC.jpg

Fast-tracked stroke drug for humans shows promise, in mice, that it might also prove a powerful tool against dementia

USC study published in the Journal of Experimental Medicine shows that experimental drug protects against injury caused by tiny blood clots in the brain’s white matter, which can accumulate over time and lead to cognitive decline
1-Dec-2021 10:25 AM EST Add to Favorites

Newswise: 619bca2489cb1_trup.JPG

Open access content from Rockefeller University Press now available on ResearchGate

ResearchGate and Rockefeller University Press (RUP) today announced the completion of the first phase of a content syndication pilot partnership. ResearchGate users can now find full-text Immediate OA articles and a subset of five years of archival...
23-Nov-2021 11:00 AM EST Add to Favorites

Newswise: 619c02e5a0962_Khalil-et-al.jpg

By putting cancer cells to sleep, new drug could prevent tumor metastasis

A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state in which they are unable to proliferate. The study, published November 23 in the Journal of Experimental Medicine (JEM), could...
23-Nov-2021 10:00 AM EST Add to Favorites

Newswise: 618bdf735e3a3_Mao-et-al.jpg

Yale researchers develop RNA-based therapy that clears SARS-CoV-2 from mice

Researchers at Yale School of Medicine have discovered that an RNA molecule that stimulates the body’s early antiviral defense system can protect mice from a range of emerging SARS-CoV-2 variants. The study, published today in the Journal of...
10-Nov-2021 10:30 AM EST Add to Favorites

Newswise: 61799ae1f3582_JEM-MSKCME.jpg

Journal of Experimental Medicine and Memorial Sloan Kettering Cancer Center Collaborate on New CME opportunities

Journal of Experimental Medicine is now presenting opportunities to engage in Continuing Medical Education (CME) in collaboration with Memorial Sloan Kettering Cancer Center. Each Journal-Based CME activity consists of a full-text article that is...
28-Oct-2021 10:00 AM EDT Add to Favorites

Newswise: 615da52e59f8c_Shinnakasu-et-al.jpg

Researchers demonstrate vaccination approach in mice that could prevent future coronavirus outbreaks

Researchers in Japan have developed a vaccination strategy in mice that promotes the production of antibodies that can neutralize not only SARS-CoV-2 but a broad range of other coronaviruses as well. If successfully translated to humans, the...
6-Oct-2021 9:40 AM EDT Add to Favorites

Newswise: 615ef549b2bb8_3_Web_Sq_RUP-VIVA.jpg

VIVA and Rockefeller University Press Establish Read-and-Publish Agreement

Virginia’s academic library consortium, VIVA, and Rockefeller University Press (RUP) have entered into a Read-and-Publish Agreement. This agreement is the first of its kind for RUP in the United States and represents an important milestone in its...
7-Oct-2021 10:00 AM EDT Add to Favorites

Rockefeller University Press Secures Transformative Journal Status from cOAlition S

Rockefeller University Press (RUP) has attained Plan S compliant Transformative Journal status from cOAlition S. Authors receiving funding from members of cOAlition S may be eligible to have their Immediate Open Access (OA) fees covered in Journal...
27-Sep-2021 10:00 AM EDT Add to Favorites

See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos


For more than 100 years, The Rockefeller University Press has provided scientists and the public with peer-reviewed results of groundbreaking research and vital news and information they can trust. The Press publishes three journals: The Journal of Experimental Medicine (1896), The Journal of General Physiology (1918), and The Journal of Cell Biology (1955). The Press uses the latest technologies to fulfill its commitment to quality and integrity in scientific publishing.


Ben Short
Senior Science Writer



Rory Williams
Director of Communications and Marketing


212- 327-8603

Rory Williams
Director, Communications and Marketing